Examkin

Soru

Zorluk: ZorPreventive Care and Immunizations

A 2-month-old girl is brought to the clinic for a routine well-child visit. She was born at 39 weeks gestation via uncomplicated vaginal delivery. Her mother has severe Crohn disease and was treated with infliximab throughout the pregnancy. The infant is exclusively breastfed, feeds well, and is gaining weight appropriately. Her physical examination is unremarkable. She received the hepatitis B vaccine at birth. The pediatrician discusses the routine 2-month immunizations, which normally include the diphtheria, tetanus, and acellular pertussis (DTaP); Haemophilus influenzae type b (Hib); inactivated poliovirus (IPV); pneumococcal conjugate (PCV); and rotavirus vaccines. Based on this patient's history, which of the following is the most appropriate recommendation regarding her immunizations today?

  1. A
    Administer all routine 2-month vaccines as scheduled.
  2. Withhold the rotavirus vaccine and administer the remaining routine vaccines.Cevap
  3. C
    Withhold the rotavirus and inactivated poliovirus vaccines, and administer the remaining routine vaccines.
  4. D
    Administer all routine 2-month vaccines and advise the mother to temporarily discontinue breastfeeding.
  5. E
    Delay all routine immunizations until the infant is at least 6 months of age.

Cevap

Withhold the rotavirus vaccine and administer the remaining routine vaccines.
The correct recommendation is to withhold the rotavirus vaccine and administer all other routine 2-month vaccines. Infliximab is an IgG1 monoclonal antibody that actively crosses the placenta, particularly in the third trimester. Consequently, infants born to mothers receiving this biologic therapy are born with therapeutic serum levels of the drug, rendering them functionally immunocompromised for up to 6 months of age. According to the CDC, live-attenuated vaccines are contraindicated in these infants during this 6-month window due to the risk of uncontrolled vaccine-strain viral replication. Of the routine 2-month immunizations, only the rotavirus vaccine is live-attenuated. The other scheduled vaccines (DTaP, Hib, IPV, and PCV) are inactivated and are safe and highly recommended to prevent life-threatening childhood illnesses.

Adım Adım Çözüm

1
Identify the maternal medication and its pharmacokinetic properties during pregnancy.
The mother took infliximab, an IgG1 monoclonal antibody targeting TNF-alpha.
IgG antibodies actively cross the placenta, primarily during the third trimester, providing passive immunity but also transferring any IgG-based medications.
2
Determine the clinical implication for the infant.
The infant is considered functionally immunocompromised.
Because infliximab crosses the placenta, the infant can have detectable serum levels of the immunosuppressive drug for up to 6 months after birth.
3
Apply general immunization guidelines for immunocompromised patients.
Live-attenuated vaccines are strictly contraindicated.
Immunocompromised individuals lack the cellular immunity to control live-attenuated viruses, placing them at risk for disseminated vaccine-strain infection.
4
Evaluate the standard 2-month vaccine schedule to identify any live vaccines.
Rotavirus is the only live vaccine on the 2-month schedule.
DTaP, Hib, IPV, and PCV are all inactivated, toxoid, or recombinant subunit vaccines and are safe to administer.
5
Formulate the final management plan.
Withhold the rotavirus vaccine, but give DTaP, Hib, IPV, and PCV.
Inactivated vaccines are safe and essential for protecting the vulnerable infant, while the live rotavirus vaccine poses a life-threatening risk.

Anahtar Kavram

Infants exposed to maternal immunosuppressive biologics (like TNF-alpha inhibitors) in utero are considered immunocompromised for the first 6 months of life, making early live vaccines (e.g., rotavirus) contraindicated.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru